Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Operating Margin (2021 - 2024)

Solid Biosciences' Operating Margin history spans 4 years, with the latest figure at 53194.67% for Q4 2024.

  • For Q4 2024, Operating Margin changed N/A year-over-year to 53194.67%; the TTM value through Dec 2024 reached 38155.29%, down 678091.0%, while the annual FY2024 figure was 38155.29%, N/A changed from the prior year.
  • Operating Margin for Q4 2024 was 53194.67% at Solid Biosciences, up from 42904.88% in the prior quarter.
  • Across five years, Operating Margin topped out at 53194.67% in Q4 2024 and bottomed at 1318.03% in Q1 2022.
  • The 4-year median for Operating Margin is 12304.97% (2023), against an average of 16980.68%.
  • The largest annual shift saw Operating Margin crashed -81170bps in 2022 before it skyrocketed 2778910bps in 2023.
  • A 4-year view of Operating Margin shows it stood at 509.78% in 2021, then surged by 184bps to 427.06% in 2022, then soared by 5563bps to 24182.88% in 2023, then soared by 120bps to 53194.67% in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Operating Margin are 53194.67% (Q4 2024), 42904.88% (Q3 2024), and 31577.27% (Q2 2024).